Video Experimental Relacionado
Updated: Jan 23, 2026
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.2K
Inhibición de PAI-1 en trombosis venosa experimental
Maxim E Shaydakov1,2, Cory D Emal3, Joshua P Rainey4
1Vascular and Endovascular Surgery, WellSpan Health, York, PA, USA.
Phlebology
|January 22, 2026
Resumen
Un nuevo inhibidor de PAI-1, MDI-2268, muestra significativos efectos antitrombóticos en un modelo de ratón de trombosis venosa. Este novedoso agente profibrinolítico reduce eficazmente el peso del trombo sin aumentar el tiempo de sangrado.
Área de la Ciencia:
- Farmacología
- Investigación de Trombosis
- Desarrollo de Fármacos
Sus antecedentes:
- El inhibidor 1 del activador del plasminógeno (PAI-1) juega un papel clave en la trombosis.
- Se ha desarrollado un nuevo inhibidor de PAI-1, MDI-2268.
- Evaluar la eficacia y seguridad de MDI-2268 es crucial para posibles aplicaciones terapéuticas.
Objetivo del estudio:
- Evaluar los efectos antitrombóticos de MDI-2268 en un modelo in vivo de trombosis venosa aguda (TV).
- Evaluar el perfil de seguridad de MDI-2268, específicamente su efecto sobre el tiempo de sangrado.
- Comparar la eficacia de MDI-2268 con la enoxaparina, un anticoagulante estándar.
Principales métodos:
- Se estableció un modelo de TV por lesión electrolítica en ratones C57BL/6.
- Los ratones fueron tratados con diferentes dosis de MDI-2268, enoxaparina o una combinación.
- Se midió el peso del trombo y el tiempo de sangrado de la cola el día 2 después de la lesión.
Principales resultados:
- MDI-2268 demostró una reducción dosis-dependiente del peso del trombo.
- Tanto MDI-2268 (3 mg/kg) como la enoxaparina redujeron significativamente el peso del trombo en comparación con los controles.
- MDI-2268 no prolongó significativamente el tiempo de sangrado de la cola en las dosis probadas.
Conclusiones:
- MDI-2268 es un novedoso agente profibrinolítico con potente actividad antitrombótica.
- MDI-2268 muestra un perfil de seguridad favorable, sin un aumento significativo del tiempo de sangrado.
- MDI-2268 representa un candidato terapéutico prometedor para el manejo de la trombosis venosa aguda.
Videos de Conceptos Relacionados
01:30Venous Thrombosis I: Introduction
415
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
415
01:29Venous Thrombosis III: Interprofessional Care
286
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
286
01:30Venous Thrombosis IV: Nursing Management
208
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
208
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
314
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
314
00:46Feedback Inhibition
56.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
01:04Venous Return
11.8K
The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
11.8K